Please assess the completion status of the following clinical trial:

Trial Title: Ultrasound and Photoacoustic Imaging for Cervical Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
* Diagnosis of cervical cancer of any stage that will be treated with radiation therapy and concurrent chemotherapy.~* At least 18 years of age.~* Not pregnant and/or breastfeeding.~* Able to understand and willing to sign an IRB-approved written informed consent document.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Transvaginal probe (Photoacoustic + ultrasound imaging) (Type: EXPERIMENTAL): * A transvaginal imaging probe using ultrasound and photoacoustic imaging will be inserted into the vagina and will use different frequencies of lights to create images~* This will occur before the first standard of care treatment, mid-treatment, end of treatment, and approximately 3 months after the end of treatment for a total of 4 imaging time points

Based on this trial design, predict the completion outcome and termination type (if applicable).